Sartorius and DIANT Pharma Inc. are joining forces to address critical challenges in nanoparticle-based drug encapsulation

With a focus on mRNA therapies, oncology treatments, and targeted vaccines, our goal is to simplify drug formulation, improve consistency, and accelerate timelines from discovery to commercialization. We will achieve this by combining cutting-edge expertise and industry leading technologies to enable researchers to more efficiently deliver advanced therapies to patients.